Pages that link to "Q38099416"
Jump to navigation
Jump to search
The following pages link to Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. (Q38099416):
Displaying 16 items.
- The benefits of integration (Q26750867) (← links)
- Specific in vivo knockdown of protein function by intrabodies (Q26801077) (← links)
- Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors (Q33903154) (← links)
- Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo (Q33945680) (← links)
- In vitro functional correction of Hermansky-Pudlak Syndrome type-1 by lentiviral-mediated gene transfer (Q34788332) (← links)
- MiRNA inhibition in tissue engineering and regenerative medicine (Q35799937) (← links)
- Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells (Q36370665) (← links)
- Impact of Different Promoters on Episomal Vectors Harbouring Characteristic Motifs of Matrix Attachment Regions (Q36937744) (← links)
- "Model t" cells: a time-tested vehicle for gene therapy (Q37201423) (← links)
- Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. (Q37664729) (← links)
- Poly(amidoamine) dendrimer complexes as a platform for gene delivery. (Q38156233) (← links)
- The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells (Q38430935) (← links)
- The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System (Q40295198) (← links)
- CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells (Q41899254) (← links)
- Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety (Q50056661) (← links)
- Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic. (Q54262475) (← links)